RxDoctor Payments DataLook up a doctor →

Frank Don, DO

Dermatology · Hallandale Beach, FLNPI 1821248022

Payments from drug & device makers

$7,506,887in general payments, 2019–2025

Across 2,155 payments — averaging $3483.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$3M
  • Sanofi US Services Inc.$1.2M
  • Incyte Corporation$1M
  • Eli Lilly$953K
  • AbbVie$594K
  • Dr.reddy's Laboratories,inc.$298K
  • plus $441K from 43 others

What the payments were for

  • Consulting fees$5,9482%
  • Speaking & faculty fees$215,71880%
  • Travel & lodging$12,8475%
  • Food & beverage$34,19613%
  • Education$3570%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,506,887 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$573,143
Medicare patients
892
Services billed
4,639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EnbrelEtanercept57$433,430
Clobetasol Propionate687$62,134
Fluocinolone Acetonide104$11,869
Calcipotriene30$7,657
Doxycycline Hyclate586$6,676
Desonide58$6,606
Acyclovir32$5,162
Mupirocin834$4,990
Ketoconazole464$4,982
Triamcinolone Acetonide379$4,562
Clindamycin Phosphate86$4,528
Ammonium Lactate253$4,457
Tacrolimus19$4,422
Fluorouracil28$4,190
Fluocinolone AcetonideFluocinolone/Shower Cap26$3,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$2,156$433,43057 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,147 dermatology providers in Florida.

Other dermatology in Hallandale Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →